Act fast, stop COVID: The successful implementation of the first decentralised Victorian COVID-19 contact tracing and monitoring unit.
McNamara BJ, McDonald J, Heard K, Friedman ND, Diver F, Athan E, Wade AJ, Brennan F, Warburton M, Bartolo C, Maggs C, Miller N, Smith M, Stenos J, O'Brien DP
COVID-19
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C).
Clark PJ, Valery PC, Strasser SI, Weltman M, Thompson A, Levy MT, Leggett B, Zekry A, Rong J, Sinclair M, George J, Sievert W, MacQuillan G, Tse E, Nicoll A, Wade A, Cheng W, Roberts SK
Alcohol and Other Drugs Hepatitis C
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol.
Doyle JS, Heath K, Elsum I, Douglass C, Wade A, Kasza J, Allardice K, Von Bibra S, Chan K, Camesella B, Guzman R, Bryant M, Thompson AJ, Stoové MA, Snelling TL, Scott N, Spelman T, Anderson D, Richmond J, Howell J, Andric N, Dietze PM, Higgs P, Sacks-Davis R, Forbes AB, Hellard ME, Pedrana AE
Hepatitis C
Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients.
Roder C, Cosgrave C, Mackie K, McNamara B, Doyle JS, Wade AJ
Hepatitis C
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care.
Clark PJ, Valery PC, Strasser SI, Weltman M, Thompson A, Levy MT, Leggett B, Zekry A, Rong J, Sinclair M, George J, Bollipo S, McGarity B, Sievert W, MacQuillan G, Tse E, Nicoll A, Wade A, Cheng W, Roberts SK
Hepatitis C
Leave no-one behind: A retrospective study of hepatitis C testing and linkage to care for hospital inpatients.
Roder C, Cosgrave C, Mackie K, Roberts SK, Hellard ME, Wade AJ, Doyle JS
Hepatitis C